Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Enveric Biosciences, Inc. Director's Dealing 2018

Aug 22, 2018

35460_dirs_2018-08-22_cc1da0fb-cadb-4983-a0aa-9201ef3d3e39.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMERI Holdings, Inc. (AMRH)
CIK: 0000890821
Period of Report: 2018-08-20

Reporting Person: LUCI DAVID P (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-08-20 Option (Right to Buy) $1.53 A 150000 Acquired Common Stock (150000) Direct
2018-08-20 Restricted Stock Unit $ A 15000 Acquired Common Stock (15000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2430 Direct

Footnotes

F1: The options vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of stockholders of the Issuer occurring after August 16, 2018. The options will expire on the fifth anniversary of the vesting date.

F2: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock.

F3: The Restricted Stock Units vest on the first anniversary of the grant date.